Novel Psychedelic Promising on Resistant Depression

Published Date: 28 Mar 2026

An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression symptoms compared to placebo, a phase 2b trial shows.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning

2.

Two-part prodrug system activates immune attack only in tumor's unique environment

3.

CD39 Blockade Shows Potential in Early-Stage Lung Cancer

4.

Medicaid expansion tied to smaller declines in early-stage cancer detection

5.

Glofitamab Regimen Improves Survival in DLBCL


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot